Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Why is the share price so low, this is such a disappointment.

Stever, you echo a lot of other peoples concern but Patriot is in a very unique situation. The money they are accumilating from these licenses are coming from a "shared" patent. The patent shared between Patriot and TPL. Currently TPL is in control regarding the recent Markamn hearings and settlements and Patriot can only idly stand by. We have absolutely nothing to do with the litigation. In addition, Patriot must abide to a Non disclosure until sometime in april.

This does not mean Patriot is doomed.  PTSC is sitting on millions and low debt. What we need is hopefully more information about the settlement sometime after April, and to get news of some "aquisitions" that Mr Turley has mentioned in the past. We are sitting pretty with everything in hand now to grow this baby as a "real" company if management steers it correctly. Patriot just cant say anything about the settlement details and thats what has brought the price down. I have no doubts future details and news of other business will bring us back up to the numbers we'd expect.

Sorry for typos. 

 

3
Jan 06, 2008 05:10PM
Share
New Message
Please login to post a reply